IRIS
ROMANO, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.771
EU - Europa 5.431
AS - Asia 5.210
SA - Sud America 787
AF - Africa 711
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 21.921
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.445
SG - Singapore 2.482
RU - Federazione Russa 1.769
IT - Italia 1.524
CN - Cina 1.504
IE - Irlanda 690
BR - Brasile 633
CI - Costa d'Avorio 423
VN - Vietnam 408
UA - Ucraina 401
KR - Corea 287
FR - Francia 237
CA - Canada 236
GB - Regno Unito 163
DE - Germania 148
IN - India 119
NG - Nigeria 112
SE - Svezia 94
FI - Finlandia 93
BD - Bangladesh 76
PL - Polonia 65
AR - Argentina 63
SN - Senegal 62
MX - Messico 58
NL - Olanda 58
JP - Giappone 52
HK - Hong Kong 46
TR - Turchia 39
ZA - Sudafrica 37
IQ - Iraq 35
ES - Italia 33
BE - Belgio 26
CZ - Repubblica Ceca 26
BJ - Benin 25
CL - Cile 21
UZ - Uzbekistan 21
ID - Indonesia 19
CH - Svizzera 18
IR - Iran 18
EC - Ecuador 17
VE - Venezuela 15
AT - Austria 14
CO - Colombia 14
LT - Lituania 14
MA - Marocco 14
SA - Arabia Saudita 14
PK - Pakistan 13
GR - Grecia 12
LB - Libano 11
IL - Israele 10
PY - Paraguay 10
AE - Emirati Arabi Uniti 9
EG - Egitto 9
JO - Giordania 9
DO - Repubblica Dominicana 8
RO - Romania 8
AL - Albania 7
KE - Kenya 7
PH - Filippine 6
TN - Tunisia 6
AU - Australia 5
DZ - Algeria 5
NO - Norvegia 5
PE - Perù 5
AZ - Azerbaigian 4
GT - Guatemala 4
HR - Croazia 4
KZ - Kazakistan 4
NI - Nicaragua 4
UY - Uruguay 4
BB - Barbados 3
EU - Europa 3
MY - Malesia 3
OM - Oman 3
PA - Panama 3
RS - Serbia 3
SI - Slovenia 3
SV - El Salvador 3
TH - Thailandia 3
BF - Burkina Faso 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
CY - Cipro 2
DK - Danimarca 2
ET - Etiopia 2
HN - Honduras 2
JM - Giamaica 2
KH - Cambogia 2
LU - Lussemburgo 2
LV - Lettonia 2
MT - Malta 2
NP - Nepal 2
SR - Suriname 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
Totale 21.902
Salva come PNG Salva come JPEG
Città #
Dallas 1.835
Singapore 1.489
Santa Clara 1.138
Moscow 813
San Jose 713
Dublin 682
Chandler 577
Ashburn 575
Hefei 442
Jacksonville 440
Chicago 428
Abidjan 423
Houston 390
Catania 317
Boardman 290
Seoul 286
Los Angeles 237
Beijing 215
Lauterbourg 189
Lawrence 142
Cambridge 141
Andover 135
Nanjing 134
New York 132
Ho Chi Minh City 130
Toronto 124
Council Bluffs 118
Civitanova Marche 113
Florence 107
Hanoi 85
São Paulo 77
Des Moines 71
Milan 70
Buffalo 69
Rome 64
Dakar 62
San Mateo 59
Abuja 56
Warsaw 55
Wilmington 51
Montreal 50
Lagos 48
Dong Ket 45
Nanchang 45
Orem 44
Hong Kong 43
Tokyo 43
Washington 43
Palermo 42
Helsinki 41
Saint Petersburg 41
Messina 40
Stockholm 38
London 36
Munich 36
Hebei 35
Lappeenranta 33
Amsterdam 32
Brooklyn 31
Poplar 31
Tianjin 31
Ottawa 29
Shenyang 29
Grafing 28
Seattle 28
Cotonou 25
Denver 25
Atlanta 23
Boston 23
Brussels 23
Johannesburg 23
Jiaxing 21
The Dalles 21
Mexico City 20
Naples 20
Paris 20
Rio de Janeiro 20
Ankara 19
Bremen 19
Chennai 19
Mumbai 19
Turku 19
Changsha 18
Kochi 18
Phoenix 18
San Francisco 18
Columbus 17
Baghdad 16
Charlotte 15
Frankfurt am Main 15
Tehran 15
Bari 13
Guangzhou 13
Redondo Beach 13
Bernareggio 12
Brno 12
Bronte 12
City of London 12
Fortaleza 12
Piscataway 12
Totale 15.036
Salva come PNG Salva come JPEG
Nome #
Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy 295
Childhood neurofibromatosis type 2 (NF2) and related disorders: From bench to bedside and biologically targeted therapies [Neurofibromatosi tipo 2 (NF2) e sindromi correlate in età infantile: dalla biologia molecolare alla pratica clinica e nuove terapie con farmaci biologici] 283
α-Lipoic Acid Reduces Iron-induced Toxicity and Oxidative Stress in a Model of Iron Overload 225
CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment 217
Inhibition of TLR4 signaling affects mitochondrial fitness and overcomes bortezomib resistance in myeloma plasma cells 207
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 200
In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection 199
Lactate accumulation promotes immunosuppression and fibrotic transformation of bone marrow microenvironment in myelofibrosis 198
Antiproliferative and Antiangiogenic Effects of Punica granatum Juice (PGJ) in Multiple Myeloma (MM) 197
"MESENTERIUM COMMUNE" IN GIOVANE ADULTO. UN RARO CASO CLINICO 188
Focus on Osteosclerotic Progression in Primary Myelofibrosis 186
A Phase III Study of Enoxaparin Vs Aspirin as Thromboprophylaxis for Newly Diagnosed Myeloma Patients Treated with Lenalidomide-Based Regimen 181
A Reciprocal Link between Oral, Gut Microbiota during Periodontitis: The Potential Role of Probiotics in Reducing Dysbiosis-Induced Inflammation 179
Heme oxygenase-1 nuclear translocation regulates bortezomib-induced cytotoxicity and mediates genomic instability in myeloma cells. 179
Ixazomib improves bone remodeling and counteracts sonic hedgehog signaling inhibition mediated by myeloma cells 179
Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno-microenvironment in multiple myeloma 165
NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) IMPROVES THE RISK ASSESSMENT OF ISS STAGING IN NEWLY DIAGNOSED MM PATIENTS TREATED UPFRONT WITH NOVEL AGENTS 164
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53 164
Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab 163
Hedgehog signaling pathways in multiple myeloma 163
Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy via STAT3 159
High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signaling 159
Mesenchymal stromal cells in tumor microenvironment remodeling of BCR-ABL negative myeloproliferative diseases 157
A case of high-risk AML in a patient with advanced systemic mastocytosis 156
Bortezomib modulates CHIT1 and YKL40 in monocyte-derived osteoclast and in myeloma cells. 156
Enhanced Antitumor Activity by the Combination of Dasatinib and Selinexor in Chronic Myeloid Leukemia 155
Bortezomib Inhibits Osteoclastogenesis and Bone Resorption Through Modulation of CHIT1 and YKL40 Expression 153
A snapshot of asparaginase-induced liver insufficiency. 150
Mitochondrial Functions, Energy Metabolism and Protein Glycosylation are Interconnected Processes Mediating Resistance to Bortezomib in Multiple Myeloma Cells 149
Immune off-target effects of Brentuximab Vedotin in relapsed/refractory Hodgkin Lymphoma 148
A Real-Life Survey of Venous Thromboembolic Events Occurring in Myeloma Patients Treated in Third Line with Second-Generation Novel Agents 148
Monocytic myeloid-derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib 147
Myeloma Patient With Brugada Syndrome and Successful Lenalidomide Treatment 144
Acute GVHD after allogeneic hematopoietic transplantation affects early marrow reconstitution and speed of engraftment 144
Immune Response and Breakthrough Infection Risk After SARS-CoV-2 Vaccines in Patients with Hemoglobinopathy: A Single Center Experience 143
Analysis of metabolic parameters coming from basal and interim PET in hodgkin lymphoma 143
BORTEZOMIB INHIBITS OSTEOCLASTOGENESIS AND MODULATE CHIT1 AND YKL40 EXPRESSION 142
Absolute Count of Myeloid Derived Suppressor Cells (MDSC) Is Able to Predict the Response to Early-PET In Hodgkin Lymphoma 142
Clinical Benefit of Long-Term Disease Control with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients 141
Belantamab Mafodotin and Relapsed/Refractory Multiple Myeloma: This Is Not Game Over 141
ARGINASE 1 IS A MARKER OF MYELOID-MEDIATED IMMUNOSUPPRESSION WITH PROGNOSTIC MEANING IN CLASSIC HODGKIN'S LYMPHOMA 141
PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy 141
TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma 139
Mesenchymal stem cells (MSC) promotes tumor microenvironment transformation driving Granulocyte-like Myeloid Derived Suppressor Cells (G-MDSC) activation in Smoldering and Multiple Myeloma patients 138
Iron regulates myeloma cell/macrophage interaction and drives resistance to bortezomib 138
Bortezomib Inhibits Osteoclastogenesis and Bone Resorption Through Modulation of CHIT1 and YKL40 Expression 137
Clinical impact of the immunome in lymphoid malignancies: the role of Myeloid-Derived Suppressor Cells 137
Multiple Myeloma in 2023 Ways: From Trials to Real Life 136
Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine 136
Saprochete capitata: Emerging Infections from Uncommon Microorganisms in Hematological Diseases 134
Correction: TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma (Cell Death & Disease, (2019), 10, 10, (704), 10.1038/s41419-019-1959-5) 132
Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: A phase III, open-label, randomized trial 132
CIRCULATING ARGINASE-1 IN SERUM IS A NOVEL BIO-MARKERIN HODGKIN LYMPHOMA 131
Bone turnover markers in patients with type 1 Gaucher disease 131
Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network 130
CD200 EXPRESSION ON MYELOMA CELLS AND ANTITUMOR IMMUNITY 129
A rare case of multiple myeloma with intracranial extramedullary relapse: One or more myeloma clones? 129
Efficacy and safety of tixagevimab-cilgavimab versus SARS-CoV-2 breakthrough infection in the hematological conditions 126
Carbon nanotube-based sensing devices for human Arginase-1 detection 125
Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological Cancers 124
Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional study 122
The NLR and LMR ratio in newly diagnosed MM patients treated upfront with novel agents 122
The Role of Dielectrophoresis for Cancer Diagnosis and Prognosis 122
Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life Survey 121
MacroH2A1.1 as a crossroad between epigenetics, inflammation and metabolism of mesenchymal stromal cells in myelodysplastic syndromes 120
CD200 expression in patients with multiple myeloma: Another piece of the puzzle 120
Advanced Stage Hodgkin Lymphoma: Patient Management 120
Label-Free Enrichment of Circulating Tumor Plasma Cells: Future Potential Applications of Dielectrophoresis in Multiple Myeloma 119
The Neutrophil-to-Lymphocyte Ratio is Related to Disease Activity in Relapsing Remitting Multiple Sclerosis 118
Single segment of spleen autotransplantation, after splenectomy for trauma, can restore splenic functions 118
Abnormal F-18 fluorodeoxyglucose uptake of the lung in immunocompromised lymphoma patients in complete remission: Report of two cases and revision of literature 117
Addressing Non-linear System Dynamics of Single-Strand RNA Virus-Host Interaction 116
Advances in understanding regulatory myeloid cells 116
Role of Serum Free Light Chain Assay in Relapsed/Refractory Multiple Myeloma. A Real-Life Unicentric Retrospective Study 115
Myelofibrosis and Survival Prognostic Models: A Journey between Past and Future 112
HIGH-RESOLUTION SNP ARRAYS AS AN ADDITIONAL TOOL TO SEARCH FOR GENETIC DEFECTS INVOLVED IN PROGRESSION FROM MYELODYSPLASTIC SINDROME TO ACUTE LEUKEMIA 112
Serum free light chains and multiple myeloma: Is it time to extend their application? 112
Proteomic analysis reveals autophagy as pro-survival pathway elicited by long-term exposure with 5-azacitidine in high-risk myelodysplasia 111
Endoscopic features of gastro-intestinal lymphomas: From diagnosis to follow-up 110
IGFBP-6/sonic hedgehog/TLR4 signalling axis drives bone marrow fibrotic transformation in primary myelofibrosis 110
Mitochondrial Bioenergetics at the Onset of Drug Resistance in Hematological Malignancies: An Overview 110
Brentuximab vedotin in association with bendamustine in refractory or multiple relapsed Hodgkin lymphoma. A retrospective real-world study 109
Broad copy neutral-loss of heterozygosity regions and rare recurring copy number abnormalities in normal karyotype-acute myeloid leukemia genomes 107
Immunological Subsets Characterization in Newly Diagnosed Relapsing–Remitting Multiple Sclerosis 107
Impact of buffer composition on biochemical, morphological and mechanical parameters: A tare before dielectrophoretic cell separation and isolation 106
NEUTROPHIL TO LYMPHOCYTE RATIO IMPROVES THE RISK ASSESSMENT OF ISS STAGING IN NEWLY DIAGNOSED MM PATIENTS TREATED UPFRONT WITH NOVEL AGENTS 106
SMOLDERING MYELOMA: WALKING THROUGH RISK FACTORS AND TENTATIVE CLASSIFICATION SYSTEMS 105
Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients 103
Rate of fungal infections in patients with acute myeloid leukemia during induction treatment performing two prophylactic strategies: preliminary results 101
Aplastic Anemia & MDS International Foundation (AA&MDSIF): Bone marrow failure disease scientific symposium 2012 100
TLR4 Signaling and Heme Oxygenase-1/Carbon Monoxide Pathway Crosstalk Induces Resiliency of Myeloma Plasma Cells to Bortezomib Treatment 100
IMATINIB INCREASES CYTOTOXICITY OF MELPHALAN AND DECREASES PROLONGATION OF G2-M PHASE IN HUMAN K562 CELLS 100
Detection of fungal dna in lysis-centrifugation blood culture for the prevision of response to antifungal in aml patients with persistent neutropenic fever: a pilot subset 99
Monocytic Myeloid Derived Suppressor CELLS (M-MDSC) As Prognostic Factor in Chronic Myeloid Leukemia Patients Treated with Dasatinib 97
Reduced Absolute Count of Monocytes in Patients Carrying Hematological Neoplasms and SARS-CoV2 Infection 97
Multicentric Castleman disease and concurrent hematological disorders: the occurrence of plasmacytoma and the hypotheses arising from literature's review 96
BROAD COPY NEUTRAL-LOSS OF HETEROZYGOSITY REGIONS AND RARE RECURRING COPY NUMBER ABNORMALITIES IN KARYOTYPICALLY NORMAL ACUTE MYELOID LEUKEMIA GENOMES 96
Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma 95
Bortezomib induced expression of heme oxygenase 1 via endoplasmic reticulum stress 19th Congress of the European-Hematology-Association. Milan, ITALY. Jun 12-15, 2014. 94
HS-TROPONINE T RELATES WITH MYOCARDIAL IRON OVERLOAD IN TRANSFUSION DEPENDENT THALASSEMIC PATIENTS 93
Totale 13.929
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.783
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.783
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202182 0 0 0 0 0 0 0 0 0 0 0 82
2021/20221.094 112 151 8 11 190 21 153 60 102 16 33 237
2022/20232.113 157 114 31 131 229 362 9 363 522 34 108 53
2023/20241.339 59 195 74 105 70 295 31 104 9 32 217 148
2024/20254.574 57 736 287 216 943 508 150 208 334 381 354 400
2025/202610.786 625 1.173 1.659 728 1.592 2.039 1.080 235 570 637 286 162
Totale 22.233